J P Steele

Summary

Affiliation: Queen Mary
Country: UK

Publications

  1. ncbi Phase II study of vinorelbine in patients with malignant pleural mesothelioma
    J P Steele
    Department of Medical Oncology, St Bartholomew s Hospital, and the London Lung Cancer Group, London, United Kingdom
    J Clin Oncol 18:3912-7. 2000
  2. ncbi Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma
    J P Steele
    Department of Medical Oncology, St Bartholomew s Hospital, Royal Free and University College Medical School, London, UK
    Ann Oncol 12:497-9. 2001
  3. ncbi Gemcitabine/carboplatin versus cisplatin/etoposide for patients with poor-prognosis small cell lung cancer: a phase III randomized trial with quality-of-life evaluation
    J P Steele
    Department of Medical Oncology, St Bartholomew's Hospital, London, EC1A 7BE, UK
    Semin Oncol 28:15-8. 2001

Collaborators

Detail Information

Publications3

  1. ncbi Phase II study of vinorelbine in patients with malignant pleural mesothelioma
    J P Steele
    Department of Medical Oncology, St Bartholomew s Hospital, and the London Lung Cancer Group, London, United Kingdom
    J Clin Oncol 18:3912-7. 2000
    ..To evaluate the response rate and impact on quality of life of vinorelbine given as cycles of 30 mg/m(2) weekly for 6 weeks to patients with malignant pleural mesothelioma...
  2. ncbi Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma
    J P Steele
    Department of Medical Oncology, St Bartholomew s Hospital, Royal Free and University College Medical School, London, UK
    Ann Oncol 12:497-9. 2001
    ..To assess the response rate, toxicity and survival in patients with malignant pleural mesothelioma treated with liposomal daunorubicin. The study design allowed for dose escalation pending toxicity...
  3. ncbi Gemcitabine/carboplatin versus cisplatin/etoposide for patients with poor-prognosis small cell lung cancer: a phase III randomized trial with quality-of-life evaluation
    J P Steele
    Department of Medical Oncology, St Bartholomew's Hospital, London, EC1A 7BE, UK
    Semin Oncol 28:15-8. 2001
    ..This London Lung Cancer Group trial of gemcitabine/carboplatin may define an active, safe, and acceptable treatment for patients with extensive-stage and poor-prognosis small cell lung cancer. Semin Oncol 28 (suppl 10):15-18...